Company / Accounts Receivable
Orthofix Medical Inc. Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$135.7M
FY2025
5-year range
$78.6M / $135.7M
FY2021-FY2025
Trend
+0.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable has increased for 5 consecutive years, from $72M in FY2020 to $136M in FY2025.
Based on SEC 10-K filings.
$136M in FY2025 with a 5-year CAGR of +13.4%.
Improved from $128M to $136M over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +17.9%
- 5-Year CAGR
- +13.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- Orthofix Medical Inc.'s accounts receivable has grown for 5 consecutive years.
- 5-year CAGR of +13.4%, indicating consistent growth.
- In FY2025, accounts receivable increased 0.8% year-over-year.
- Lowest accounts receivable in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $135.7M | +0.8% |
| FY2024 | $134.7M | +5.2% |
| FY2023 | $128.1M | +54.6% |
| FY2022 | $82.9M | +5.5% |
| FY2021 | $78.6M | +8.5% |
| FY2020 | $72.4M | -16.6% |
| FY2019 | $86.8M | +11.7% |
| FY2018 | $77.7M | +22.6% |
| FY2017 | $63.4M | +9.7% |
| FY2016 | $57.8M | -3.3% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 28, 2026